AbbVie Inc.

AbbVie Inc.verified

ABBV

Price:

$179.8

Market Cap:

$317.73B

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pan...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2013-01-02

Stock Exchange

NYSE

Ticker

ABBV

The Enterprise Value as of December 2024 (TTM) for AbbVie Inc. (ABBV) is 381.55B

According to AbbVie Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 381.55B. This represents a change of 3.97% compared to the average of 367.00B of the last 4 quarters.

AbbVie Inc. (ABBV) Historical Enterprise Value (quarterly & annually)

How has ABBV Enterprise Value performed in the past?

The mean historical Enterprise Value of AbbVie Inc. over the last ten years is 210.29B. The current 381.55B Enterprise Value has changed 18.04% with respect to the historical average. Over the past ten years (40 quarters), ABBV's Enterprise Value was at its highest in in the September 2024 quarter at 413.16B. The Enterprise Value was at its lowest in in the March 2015 quarter at 100.74B.

Quarterly (TTM)
Annual

Average

210.29B

Median

178.75B

Minimum

111.01B

Maximum

340.28B

AbbVie Inc. (ABBV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AbbVie Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 62.24%

Maximum Annual Enterprise Value = 340.28B

Minimum Annual Increase = -9.80%

Minimum Annual Enterprise Value = 111.01B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023320.56B-5.80%
2022340.28B10.99%
2021306.60B19.66%
2020256.23B62.24%
2019157.93B-9.80%
2018175.09B-4.02%
2017182.41B36.83%
2016133.31B11.52%
2015119.54B7.69%
2014111.01B24.67%

AbbVie Inc. (ABBV) Average Enterprise Value

How has ABBV Enterprise Value performed in the past?

The current Enterprise Value of AbbVie Inc. (ABBV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

322.48B

5-year avg

276.32B

10-year avg

210.29B

AbbVie Inc. (ABBV) Enterprise Value vs. Peers

How is ABBV’s Enterprise Value compared to its peers?

AbbVie Inc.’s Enterprise Value is greater than Merck & Co., Inc. (275.11B), greater than Pfizer Inc. (216.86B), less than Eli Lilly and Company (783.09B), greater than Bristol-Myers Squibb Company (160.66B), greater than Johnson & Johnson (366.92B), greater than Amgen Inc. (193.56B), greater than Gilead Sciences, Inc. (135.30B),

CompanyEnterprise ValueMarket cap
275.11B$251.57B
216.86B$151.34B
783.09B$755.34B
160.66B$117.15B
366.92B$351.15B
193.56B$142.17B
135.30B$117.09B

Build a custom stock screener for AbbVie Inc. (ABBV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbbVie Inc. (ABBV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AbbVie Inc.'s Enterprise Value?

What is the highest Enterprise Value for AbbVie Inc. (ABBV)?

What is the 3-year average Enterprise Value for AbbVie Inc. (ABBV)?

What is the 5-year average Enterprise Value for AbbVie Inc. (ABBV)?

How does the current Enterprise Value for AbbVie Inc. (ABBV) compare to its historical average?